Cenova Ventures

Cenova Ventures, a principal investment firm, invests in healthcare services, diagnostics, medical devices, and pharmaceuticals.

The healthcare industry in China is one of the largest and the fastest growing in the world. What’s more, it is expected to undergo significant structural changes in the coming years. Headquartered in Shanghai, China, Cenova focuses on strategic areas with innovation and high growth potential, including pharmaceuticals, biotech, medical devices, diagnostics, and healthcare services in China. Combining significant entrepreneurial experience with access to global resources, Cenova is in a position unlike any other venture firm to help its portfolio companies achieve long-term success. Currently, the firm has two RMB venture funds under management, Cenova Healthcare Venture Fund, which primarily invests in medical technology and healthcare service companies in China, and Cenova Innovation Fund, which specifically invests in early-stage innovative pharmaceutical and biotech companies in China. Both funds are supported by significant limited partners, including the central and local National Development and Reform Commission (NDRC), U.S. Merck & Co. and other major industry leaders. With deep roots in China, global operational experience, and solid working relationships with significant governmental entities, Cenova is strategically positioned to make synergistic investments in sub-sector leaders, building important infrastructure in the evolving Chinese life sciences and healthcare industry. In addition, Cenova has access to Qualified Foreign Limited Partner (QFLP) which enables immediate conversion of foreign currency into RMB for investment directly into China.